63304-865 : Febuxostat 80 mg Oral Tablet, Film Coated


NDC63304-865
Labeler: Ranbaxy Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Febuxostat
Dosage Form: Oral Tablet, Film Coated
Application #: ANDA205392
Rev. Date: 


NDC Package Codes:

  • 63304-865-05: 500 TABLET, FILM COATED IN 1 BOTTLE (63304‑865‑05)
  • 63304-865-30: 30 TABLET, FILM COATED IN 1 BOTTLE (63304‑865‑30)
  • 63304-865-69: 10 TABLET, FILM COATED IN 1 BLISTER PACK (63304‑865‑69)

Active Ingredients:

  • Febuxostat

Dosage Strength:

  • 80 mg

Pharmaceutical Classes:

  • Xanthine Oxidase Inhibitor [EPC]
  • Xanthine Oxidase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 63304-864 Febuxostat 40 mg Oral Tablet, Film Coated by Ranbaxy Pharmaceuticals Inc.
  • 0378-3925 Febuxostat 40 mg Oral Tablet, Film Coated by Mylan Pharmaceuticals Inc.
  • 0378-3926 Febuxostat 80 mg Oral Tablet, Film Coated by Mylan Pharmaceuticals Inc.
  • 46708-190 Febuxostat 40 mg Oral Tablet, Coated by Alembic Pharmaceuticals Limited
  • 46708-191 Febuxostat 80 mg Oral Tablet, Coated by Alembic Pharmaceuticals Limited
  • 47335-721 Febuxostat 40 mg Oral Tablet, Film Coated by Sun Pharmaceutical Industries, Inc.
  • 47335-722 Febuxostat 80 mg Oral Tablet, Film Coated by Sun Pharmaceutical Industries, Inc.
  • 62332-190 Febuxostat 40 mg Oral Tablet, Coated by Alembic Pharmaceuticals Inc.
  • 62332-191 Febuxostat 80 mg Oral Tablet, Coated by Alembic Pharmaceuticals Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 63304-865 QR Code

< Prev: 63304-864Next: 63304-873 >

Related Discussions:

uloric febuxostat tabletdia
Iam on uloric (febuxostat. )tablets80 mg ## Hello, Henry! How are you? Uloric is most commonly used to treat high levels... 1 reply
febuxostat
what is it i suffer from acute gout and allupurinol does not work just makes it worse suffered for 20 years...




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA